Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-020415

Head of Pharm Ops and Tech gave up 319 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 1,080 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-01 Exercise or conversion : show line 1 in the form +255 2,170.29 D
2022-08-01 Shares withheld for taxes : show line 2 in the form −76 $209.26 $15,904 2,094.29 D
2022-08-01 Exercise or conversion : show line 3 in the form +825 2,919.29 D
2022-08-01 Shares withheld for taxes : show line 4 in the form −243 $209.26 $50,850 2,676.29 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-08-01 Other disposition : show line 5 in the form Restricted Stock Unit −299 255 D
2022-08-01 Exercise or conversion : show line 6 in the form Restricted Stock Unit −255 0 D
2022-08-01 Exercise or conversion : show line 7 in the form Restricted Stock Unit −825 0 D
Loading xslF345X03/form4.xml…